Nitroglycerin (Transderm-Nitro, Nitro-Dur) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Sep 29, 2026
Also sold as: Transderm-Nitro, Nitro-Dur, Nitrostat, Nitroject
Some Nitroglycerin products are in shortage in Canada (2 of 19 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 30, 2026.
A vasodilator used to prevent and relieve chest pain (angina).
Products affected
2 / 19
In shortage since
Aug 26, 2026
Est. full return
Nov 30, 2026
Reports on file
44
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
NITROSTAT
0.6MG · TABLET · BGP PHARMA ULC
DIN 00037621 · since Sep 1, 2026, est. end Oct 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
NITROJECT
50MG · SOLUTION · JUNO PHARMA CANADA INC.
DIN 00778869 · since Aug 26, 2026, est. end Nov 30, 2026 · Disruption of the manufacture of the drug.
Resolved
NITROSTAT
0.3MG · TABLET · BGP PHARMA ULC
DIN 00037613 · ended May 29, 2026 · Disruption of the manufacture of the drug.
DIN 02238998 · ended Apr 8, 2024 · Demand increase for the drug.
Resolved
TRINIPATCH 0.4
0.4MG · PATCH · PALADIN LABS INC.
DIN 02230733 · ended Feb 7, 2024 · Release process delays
Resolved
NITROJECT
50MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 00778869 · ended Dec 13, 2023 · Disruption of the manufacture of the drug.
Resolved
NITROSTAT
0.6MG · TABLET · BGP PHARMA ULC
DIN 00037621 · ended Oct 25, 2023 · Demand increase for the drug.
Showing 12 of 44 reports. All reports are on file with Health Canada.
What's happening
Nitroglycerin is currently affected by 2 active shortage reports filed with Health Canada by BGP PHARMA ULC, JUNO PHARMA CANADA INC..
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Nitroglycerin is classified under “VASODILATORS USED IN CARDIAC DISEASES” (ATC C01DA).
Recent changes
Sep 29, 2026
Estimated end date pushed back : Oct 13, 2026 → Oct 20, 2026
Sep 22, 2026
Estimated end date pushed back : Sep 29, 2026 → Oct 13, 2026
Sep 9, 2026
Estimated end date pushed back : Sep 22, 2026 → Sep 29, 2026
Sep 9, 2026
New report filed
Sep 3, 2026
Status changed
Sep 3, 2026
Estimated end date pushed back : Sep 8, 2026 → Sep 22, 2026
Aug 5, 2026
New report filed
Common questions
What is Nitroglycerin used for?
A vasodilator used to prevent and relieve chest pain (angina).
When will Nitroglycerin be back in stock in Canada?
The latest manufacturer estimate is Nov 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Nitroglycerin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.